Handelsbanken Fonder AB Buys New Shares in LifeStance Health Group, Inc. (NASDAQ:LFST)

Handelsbanken Fonder AB acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 17,400 shares of the company’s stock, valued at approximately $128,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock worth $169,000 after purchasing an additional 5,767 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of LifeStance Health Group by 10.5% in the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock worth $572,000 after purchasing an additional 7,798 shares during the period. Rhumbline Advisers lifted its stake in LifeStance Health Group by 4.5% during the fourth quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock worth $1,441,000 after purchasing an additional 8,487 shares during the last quarter. Finally, MetLife Investment Management LLC grew its position in LifeStance Health Group by 14.3% in the third quarter. MetLife Investment Management LLC now owns 80,422 shares of the company’s stock valued at $563,000 after acquiring an additional 10,084 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Stock Performance

Shares of LFST opened at $7.91 on Tuesday. The company has a market capitalization of $3.03 billion, a price-to-earnings ratio of -30.42 and a beta of 1.28. The stock has a 50 day moving average of $7.81 and a 200 day moving average of $7.26. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $8.61.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a report on Friday. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Monday, December 16th. Finally, Barclays increased their price objective on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, LifeStance Health Group has an average rating of “Moderate Buy” and an average price target of $8.70.

Read Our Latest Report on LFST

LifeStance Health Group Profile

(Free Report)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Further Reading

Institutional Ownership by Quarter for LifeStance Health Group (NASDAQ:LFST)

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.